According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โฌ24.29 M. In 2023 the company made an earning of -โฌ23.8 M an increase over its 2022 earnings that were of -โฌ33.78 M.The earnings displayed on this page is the company's Pretax Income.